← Back to Search

GPT-4 for Diagnosis

N/A

Waitlist Available

Led By Jonathan H Chen, MD, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during evaluation

Awards & highlights

Study Summary

This trial will compare the performance of using a language model called GPT-4 to traditional diagnostic tools. The goal is to see if using GPT-4 helps with diagnosing medical cases.

Who is the study for?

This trial is for licensed physicians who have completed at least two years of post-graduate medical training (PGY2) and specialize in internal medicine, family medicine, or emergency medicine.Check my eligibility

What is being tested?

The study is testing the impact of using GPT-4, an advanced language model, on doctors' diagnostic reasoning abilities compared to traditional decision support tools in case-based scenarios.See study design

What are the potential side effects?

Since this trial involves a software tool rather than a medication or device, there are no direct physical side effects. However, potential risks could include data privacy concerns and reliance on AI for clinical decisions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during evaluation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during evaluation

This trial's timeline: 3 weeks for screening, Varies for treatment, and during evaluation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Diagnostic reasoning

Secondary outcome measures

Time Spent on Diagnosis

Trial Design

2Treatment groups

Active Control

Group I: Usual resourcesActive Control1 Intervention

Group will not be given access to GPT-4 but will be encouraged to use any resources they wish besides large language models (UpToDate, Dynamed, google, etc).

Group II: GPT-4Active Control1 Intervention

Group will be given access to GPT-4.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaOTHER

1,377 Previous Clinical Trials

1,588,246 Total Patients Enrolled

Stanford UniversityLead Sponsor

2,386 Previous Clinical Trials

17,333,958 Total Patients Enrolled

Beth Israel Deaconess Medical CenterOTHER

836 Previous Clinical Trials

13,010,286 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals presently able to enroll in this clinical trial?

"Indeed, the information provided on clinicaltrials.gov indicates that this study is presently in the recruitment phase. The initial posting of the trial occurred on November 29th, 2023, and it was last revised on December 18th, 2023. As part of the study protocol, researchers aim to enroll a total of 50 patients from a single designated location."

Answered by AI

What is the upper limit on the number of individuals who can participate in this medical trial?

"Indeed, the details available on clinicaltrials.gov indicate that this particular clinical trial is currently in search of eligible participants. The initial posting date for this study was November 29th, 2023 and the most recent update was made on December 18th, 2023. To complete the trial successfully, a total of 50 patients will be enrolled at a single designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Physician Reasoning on Diagnostic Cases With Large Language Models

Jonathan Chen 2023. "Physician Reasoning on Diagnostic Cases With Large Language Models". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06157944.